Smoking may be considered an established risk factor for sporadic ALS
- PMID: 19917993
- PMCID: PMC2788806
- DOI: 10.1212/WNL.0b013e3181c1df48
Smoking may be considered an established risk factor for sporadic ALS
Abstract
Objectives: A 2003 evidence-based review of exogenous risk factors for sporadic amyotrophic lateral sclerosis (ALS) identified smoking as the only risk factor that attained "probable" (more likely than not) status, based on 2 class II studies. The purpose of the current, evidence-based, update was to see if the conclusion of the previous review needed to be modified, based on studies published since.
Methods: A Medline literature search was conducted for the period between 2003 and April 2009 using the search terms smoking and (ALS or "amyotrophic lateral sclerosis" or MND or "motor neuron disease"). The references of primary articles and reviews were checked to assure completeness of the search. Primary articles published since the previous review were classified as before.
Results: Twenty-eight titles were identified, but only 7 articles met inclusion criteria. Of these, 1 provided class II evidence, and 1 class III evidence: both showed increased risk of ALS with smoking. The class II study showed a dose-response effect, and risk decreasing with number of years since quitting smoking. Five articles provided class IV or V evidence, which may not be relied upon to draw conclusions.
Conclusions: Smoking may be considered an established risk factor for sporadic amyotrophic lateral sclerosis (ALS) (level A rating; 3 class II studies, 1 class III study). Evidence-based analysis of epidemiologic data shows concordance among results of better-designed studies linking smoking to ALS, and lets those results drive the conclusions.
Comment in
-
Smoking may be considered an established risk factor for sporadic ALS.Neurology. 2010 Jun 8;74(23):1927; author reply 1928-9. doi: 10.1212/WNL.0b013e3181e038e9. Neurology. 2010. PMID: 20530333 No abstract available.
-
Smoking may be considered an established risk factor for sporadic ALS.Neurology. 2010 Jun 8;74(23):1927-8; author reply 1928-9. Neurology. 2010. PMID: 20549870 No abstract available.
References
-
- Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003;22:217–228. - PubMed
-
- Nelson LM, McGuire V, Longstreth WT, Jr., Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington state: I: cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156–163. - PubMed
-
- Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology 1999;18:194–202. - PubMed
-
- Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008–2012. - PubMed
-
- Weisskopf G, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. J Epidemiol 2004;160:26–33. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous